
Advancing the future of fertility.
Conception is a Berkeley-based biotechnology company developing in-vitro gametogenesis (IVG) technology to generate functional human egg cells from induced pluripotent stem cells (iPSCs). The company combines stem cell biology, 3D ovarian organoid engineering, and computational genomics to recreate the key developmental stages from iPS cells through primordial germ cells to mature eggs. High-throughput genetic screens and computer vision-based quality scoring enable rapid iteration across differentiation conditions. Conception's goal is to make biological parenthood possible for people facing age-related fertility decline or medical barriers, subject to future regulatory approval.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2024
Nov 2021
Jan 2018
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
BridgeBio makes targeted treatments for genetic diseases.